Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

[Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study].

Wahle K, Krings D, Schwenke K.

MMW Fortschr Med. 2013 Mar 21;155 Suppl 1:25-31. Review. German.

PMID:
23678668
2.
3.
4.

[Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].

Böhme K, Heckes B, Thomitzek K.

MMW Fortschr Med. 2011 Jan 13;152 Suppl 4:125-32. German.

PMID:
21598463
5.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
6.

Low-dose 7-day transdermal buprenorphine in daily clinical practice - perceptions of elderly patients with moderate non-malignant chronic pain.

Uberall MA, Müller-Schwefe GH.

Curr Med Res Opin. 2012 Oct;28(10):1585-95. doi: 10.1185/03007995.2012.731387. Epub 2012 Oct 2.

PMID:
22978772
7.

[Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].

Tschirner M, Ritzdorf I, Brünjes R.

MMW Fortschr Med. 2008 Sep 18;150 Suppl 3:142-8. German.

PMID:
19025217
8.

Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.

Griessinger N, Sittl R, Likar R.

Curr Med Res Opin. 2005 Aug;21(8):1147-56.

PMID:
16083522
9.

Transdermal buprenorphine in non-oncological moderate-to-severe chronic pain.

Gatti A, Dauri M, Leonardis F, Longo G, Marinangeli F, Mammucari M, Sabato AF.

Clin Drug Investig. 2010;30 Suppl 2:31-8. doi: 10.2165/1158409-S0-000000000-00000.

PMID:
20670047
11.
12.

Switching from high doses of pure μ-opioid agonists to transdermal buprenorphine in patients with cancer: a feasibility study.

Lundorff L, Sjøgren P, Hansen OB, Jonsson T, Nielsen PR, Christrup L.

J Opioid Manag. 2013 Jul-Aug;9(4):255-62. doi: 10.5055/jom.2013.0166.

PMID:
24353018
15.

A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.

Mitra F, Chowdhury S, Shelley M, Williams G.

Pain Med. 2013 Jan;14(1):75-83. doi: 10.1111/pme.12011.

PMID:
23320402
17.

Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study.

Karlsson J, Söderström A, Augustini BG, Berggren AC.

Curr Med Res Opin. 2014 Apr;30(4):575-87. doi: 10.1185/03007995.2013.873714. Epub 2013 Dec 23.

PMID:
24320787
18.

Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.

Correa-Illanes G, Roa RG, B Piñeros JL, Ferrer FT, Adriasola VR.

Pain Manag. 2014 May;4(3):181-90. doi: 10.2217/pmt.14.9. Epub 2014 May 16.

PMID:
24835268
19.

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Plosker GL.

Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000. Review.

PMID:
22141389
20.

High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.

Barutell C, Camba A, González-Escalada JR, Rodríguez M; Opioid Group of the Spanish Society for the Study of Pain.

Pain Pract. 2008 Sep-Oct;8(5):355-61. doi: 10.1111/j.1533-2500.2008.00205.x. Epub 2008 Jul 25.

PMID:
18662364

Supplemental Content

Support Center